Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBRX | HALO | KYMR | ||
| Company | Immunitybio Inc | Halozyme Therapeutic | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.16 | 66.31 | 88.00 | ||
| High | 8.28 | 66.47 | 88.00 | ||
| Low | 7.41 | 64.80 | 84.49 | ||
| Latest | 7.44 | 65.36 | 84.91 | ||
| Change | -0.75 | -1.23 | -2.26 | ||
| % Change | -9.16% | -1.85% | -2.59% | ||
| Volume | 16,939,801 | 1,399,600 | 393,600 | ||
| 20-Day Average Volume | 15,894,715 | 1,423,610 | 540,770 | ||
| Previous Close | 8.19 | 66.59 | 87.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.47 | 66.09 | 85.91 | ||
| 20-Day Raw Stochastic | 43.72% | 44.86% | 58.71% | ||
| 20-Day Relative Strength | 48.88 | 45.95 | 50.94 | ||
| Weighted Alpha | +11.70 | +5.66 | +71.46 | ||
| Today's Opinion | 40% Buy | 72% Sell | 88% Buy | ||
| Previous Opinion | 72% Buy | 56% Sell | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 40% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.38% since 04/17/26 | -5.67% since 04/17/26 | -3.19% since 04/17/26 | ||
| Low | 7.41 on 04/24/26 | 64.80 on 04/24/26 | 84.49 on 04/24/26 | ||
| High | 8.56 on 04/21/26 | 70.32 on 04/23/26 | 90.10 on 04/22/26 | ||
| 1-Month | |||||
| %Chg | +0.34% since 03/24/26 | +5.35% since 03/24/26 | +14.10% since 03/24/26 | ||
| Low | 6.57 on 03/30/26 | 61.33 on 03/27/26 | 75.71 on 03/25/26 | ||
| High | 8.56 on 04/21/26 | 70.32 on 04/23/26 | 90.14 on 04/15/26 | ||
| 3-Month | |||||
| %Chg | +15.35% since 01/23/26 | -5.58% since 01/23/26 | +21.42% since 01/23/26 | ||
| Low | 5.54 on 01/28/26 | 61.33 on 03/27/26 | 68.29 on 01/26/26 | ||
| High | 12.43 on 02/25/26 | 82.22 on 02/09/26 | 95.90 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | +201.21% since 10/24/25 | -1.19% since 10/24/25 | +45.00% since 10/24/25 | ||
| Low | 1.95 on 12/31/25 | 61.22 on 12/11/25 | 55.66 on 11/04/25 | ||
| High | 12.43 on 02/25/26 | 82.22 on 02/09/26 | 103.00 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,649,146 | 7,743,460 | 6,932,222 | ||
| Shares Outstanding, K | 1,028,111 | 118,474 | 81,642 | ||
| Annual Sales | 113,290,000 | 1,396,610,000 | 39,210,000 | ||
| Annual Net Income | -351,400,000 | 316,890,000 | -311,350,000 | ||
| Last Quarter Sales | 38,290,000 | 451,770,000 | 2,870,000 | ||
| Last Quarter Net Income | -61,940,000 | -141,590,000 | -86,980,000 | ||
| 60-Month Beta | 0.13 | 1.03 | 2.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 02/23/26 | -0.24 on 02/17/26 | -0.97 on 02/26/26 | ||
| Latest Earnings Date | 05/11/26 | 05/05/26 | 04/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.62 | 0.00 | ||